Chronic Kidney Disease Market

Chronic Kidney Disease Market contains market size and forecasts of Chronic Kidney Disease (CKD) in Global, including the following market information:

• Global Chronic Kidney Disease (CKD) Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Chronic Kidney Disease (CKD) market was valued at 91100 million in 2021 and is projected to reach US$ 113470 million by 2028, at a CAGR of 3.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

ACE Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Chronic Kidney Disease (CKD) include AbbVie, Allergan, Amgen, AstraZeneca, Roche, FibroGen, GlaxoSmithKline, Johnson & Johnson and Keryx, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Chronic Kidney Disease (CKD) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Chronic Kidney Disease (CKD) Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Chronic Kidney Disease (CKD) Market Segment Percentages, by Type, 2021 (%)

• ACE Inhibitors
• Calcium Channel Blockers
• Beta Blockers
• Others

Global Chronic Kidney Disease (CKD) Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Chronic Kidney Disease (CKD) Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Specialty Clinics

Global Chronic Kidney Disease (CKD) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Chronic Kidney Disease (CKD) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Chronic Kidney Disease (CKD) revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Chronic Kidney Disease (CKD) revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AbbVie
• Allergan
• Amgen
• AstraZeneca
• Roche
• FibroGen
• GlaxoSmithKline
• Johnson & Johnson
• Keryx
• Kissei
• Pfizer
• Sanofi
• Teva